GLB1 and GM1 gangliosidosis: More recently, injections of adeno‐associated viral vectors (AAV9, AAVrh8) encoding GLB1 have shown success in increasing GLB1 activity, reducing symptoms, and extending lifespan in mice with GM1 gangliosidosis (Deodato et al., 1991; Weismann et al., 2007).